scholarly journals Release of stem cells from quiescence reveals multiple gliogenic domains in the adult brain

2019 ◽  
Author(s):  
Ana C. Delgado ◽  
Angel R. Maldonado-Soto ◽  
Violeta Silva-Vargas ◽  
Dogukan Mizrak ◽  
Thomas von Känel ◽  
...  

AbstractQuiescent neural stem cells (NSCs) in the adult ventricular-subventricular zone (V-SVZ) have a regional identity and undergo activation to generate neurons. The domains for gliogenesis are less explored. Here we show that Platelet-Derived Growth Factor Receptor beta (PDGFRβ) is expressed by adult V-SVZ NSCs that generate olfactory bulb interneurons and glia with slow baseline kinetics. Selective deletion of PDGFRβ in adult V-SVZ NSCs leads to their release from quiescence uncovering multiple domains in the septal wall for oligodendrocyte and astrocyte formation. Unexpectedly, we identify a novel intraventricular oligodendrocyte progenitor inside the brain ventricles. Together our findings reveal different NSC spatial domains for gliogenesis in the adult V-SVZ that are largely quiescent under homeostasis and may have key functions for brain plasticity.

Science ◽  
2021 ◽  
Vol 372 (6547) ◽  
pp. 1205-1209 ◽  
Author(s):  
Ana C. Delgado ◽  
Angel R. Maldonado-Soto ◽  
Violeta Silva-Vargas ◽  
Dogukan Mizrak ◽  
Thomas von Känel ◽  
...  

Quiescent neural stem cells (NSCs) in the adult mouse ventricular-subventricular zone (V-SVZ) undergo activation to generate neurons and some glia. Here we show that platelet-derived growth factor receptor beta (PDGFRβ) is expressed by adult V-SVZ NSCs that generate olfactory bulb interneurons and glia. Selective deletion of PDGFRβ in adult V-SVZ NSCs leads to their release from quiescence, uncovering gliogenic domains for different glial cell types. These domains are also recruited upon injury. We identify an intraventricular oligodendrocyte progenitor derived from NSCs inside the brain ventricles that contacts supraependymal axons. Together, our findings reveal that the adult V-SVZ contains spatial domains for gliogenesis, in addition to those for neurogenesis. These gliogenic NSC domains tend to be quiescent under homeostasis and may contribute to brain plasticity.


Author(s):  
Sebastian Jessberger ◽  
Armin Curt ◽  
Roger A. Barker

A number of diseases of the brain and spinal cord are associated with substantial neural cell death and/or disruption of correct and functional neural networks. In the past, a variety of therapeutic strategies to rescue these systems have been proposed along with agents to induce functional plasticity within the remaining central nervous system (CNS) structures. In the case of injury or neurodegenerative disease these approaches have only met with limited success, indicating the need for novel approaches to treat diseases of the adult CNS. Recently, the idea of recruiting endogenous or transplanting stem cells to replace lost structures within the adult brain or spinal cord has gained significant attention, along with in situ reprogramming, and opened up novel therapeutic avenues in the context of regenerative medicine. Here we review recent advances in our understanding of how endogenous stem cells may be a part of pathological processes in certain neuropsychiatric diseases and summarize recent clinical and preclinical data suggesting that stem cell-based therapies hold great promise as a future treatment option in a number of diseases disrupting the proper function of the adult CNS.


Author(s):  
Batoul Ghaddar ◽  
Luisa Lübke ◽  
David COURET ◽  
Sepand Rastegar ◽  
Nicolas Diotel

Adult neurogenesis is an evolutionary conserved process occurring in all vertebrates. However, striking differences are observed between the taxa, considering the number of neurogenic niches, the neural stem cell (NSC) identity and brain plasticity under constitutive and injury-induced conditions. Zebrafish has become a popular model for the investigation of the molecular and cellular mechanisms involved in adult neurogenesis. Compared to mammals, the adult zebrafish displays a high number of neurogenic niches distributed throughout the brain. Furthermore, it exhibits a strong regenerative capacity without scar formation or any obvious disabilities. In this review, we will first discuss the similarities and differences regarding (i) the distribution of neurogenic niches in the brain of adult zebrafish and mammals (mainly mouse) and (ii) the nature of the neural stem cells within the main telencephalic niches. In the second part, we will describe the cascade of cellular events occurring after telencephalic injury in zebrafish and mouse. Our study clearly shows that most early events happening right after the brain injury are shared between zebrafish and mouse including cell death, microglia and oligodendrocyte recruitment, as well as injury-induced neurogenesis. In mammals one of the consequences following an injury is the formation of a glial scar that is persistent. This is not the case in zebrafish, which may be one of the main reasons that zebrafish display a higher regenerative capacity.


2013 ◽  
Vol 25 (1) ◽  
pp. 289
Author(s):  
K. C. S. Roballo ◽  
A. C. M. Ercolin ◽  
M. Bionaz ◽  
C. E. Ambrosio ◽  
M. B. Wheeler

Stroke, Parkinson’s, Alzheimer’s, and other neurological diseases that are relatively frequent in human involve loss of neurons. The advent of tissue regeneration using stem cells holds great promise in finding cures. In particular, mesenchymal stem cells (MSC) appear to be a very potent source for tissue regeneration. Among MSC subtypes, adipose-derived stem cells (ASC) have several distinct advantages. The ASC are abundant, are easy to isolate and expand in vitro, can be used for heterologous as well autologous transplants, and have multilineage differentiation capacity. In addition to osteocytes, chondrocytes, and adipocytes, the ASC have been successfully differentiated into neuronal-like cells by addition of specific neurogenic factors. However, in vivo differentiation of ASC into neurons remains to be demonstrated. In the present study, we used an in vitro system in order to evaluate whether ASC can be induced towards neurogenic lineages by physical contact with freshly isolated neurons or by factors released by neurons without addition of specific neurogenic factors. Experimentally, ASC and neurons (NEU) were extracted from the back fat or the brain, respectively, of a boar transgenic for green fluorescent protein (GFP) or from wild type pigs. The non-GFP neurons were isolated from the brain of 32-day fetuses or adult pigs. Cells were cultivated in 24-well plates with the following combinations: only ASC or NEU in DMEM (controls), ASC with conditioned medium from NEU, or ASC+NEU. Cells were harvested at 24 h and at 3, 7, 14, and 21 days and fixed with 4% paraformaldehyde in PBS for 15 min for immunohistochemistry analysis. After fixation, neuronal differentiation was evaluated by histological staining with specific neuronal markers. The proportion of ASC that differentiated into neuronal-like cells was determined using fluorescence microscopy. We observed little proliferation of ASC in conditioned medium compared with control ASC; however, a few cells exhibited neuronal-like morphology but with no expression of neuronal markers. When ASC were co-cultured with fetal NEU, starting at 3 days, we observed, using microscope analyses, that 4 to 12% of the ASC had neuronal-like morphology and expressed neuron-associated cell markers. When ASC were co-cultured with neurons from adult brain, we observed a lower fraction (between 1 and 2%) of neuronal differentiated cells starting at 7 days. Our data are preliminary but provide evidence that when ASC are in physical contact with neurons (i.e. by cell-to-cell interactions), they can be induced to differentiate into neuronal-like cells. Further, the differentiation is more rapid and extensive when the ASC are in direct contact with fetal neurons. However, further study is necessary to determine whether these neuronal-like cells are functional neurons. In this regard, we are performing electrophysiological analysis and measurement of expression of neuronal genes. In addition, flow cytometry will be used to quantify the proportion of differentiated ASC.


Author(s):  
Sebastian Jessberger ◽  
Armin Curt ◽  
Roger Barker

Several diseases of the brain and spinal cord are associated with substantial neural cell death and/or disruption of neural networks. A�variety of therapeutic strategies to rescue these systems has been proposed along with agents to induce functional plasticity within the remaining central nervous system (CNS) structures. In the case of injury or neurodegenerative disease these approaches have only met with limited success, indicating the need for novel approaches to treat diseases of the adult CNS. Recently, the idea of recruiting stem cells to replace lost structures within the adult brain or spinal cord has gained significant attention and opened up novel therapeutic avenues. Here, recent advances in our understanding of endogenous stem cells are reviewed and new clinical and preclinical data suggesting that stem cell-based therapies hold great promise as a future treatment option in a number of diseases disrupting the proper function of the adult CNS are summarized.


2016 ◽  
Vol 87 (3) ◽  
pp. 146-155 ◽  
Author(s):  
Barbara S. Beltz ◽  
Georg Brenneis ◽  
Jeanne L. Benton

The 1st-generation neural precursors in the crustacean brain are functionally analogous to neural stem cells in mammals. Their slow cycling, migration of their progeny, and differentiation of their descendants into neurons over several weeks are features of the neural precursor lineage in crayfish that also characterize adult neurogenesis in mammals. However, the 1st-generation precursors in crayfish do not self-renew, contrasting with conventional wisdom that proposes the long-term self-renewal of adult neural stem cells. Nevertheless, the crayfish neurogenic niche, which contains a total of 200-300 cells, is never exhausted and neurons continue to be produced in the brain throughout the animal's life. The pool of neural precursors in the niche therefore cannot be a closed system, and must be replenished from an extrinsic source. Our in vitro and in vivo data show that cells originating in the innate immune system (but not other cell types) are attracted to and incorporated into the neurogenic niche, and that they express a niche-specific marker, glutamine synthetase. Further, labeled hemocytes that undergo adoptive transfer to recipient crayfish generate cells in neuronal clusters in the olfactory pathway of the adult brain. These hemocyte descendants express appropriate neurotransmitters and project to target areas typical of neurons in these regions. These studies indicate that under natural conditions, the immune system provides neural precursors supporting adult neurogenesis in the crayfish brain, challenging the canonical view that ectodermal tissues generating the embryonic nervous system are the sole source of neurons in the adult brain. However, these are not the first studies that directly implicate the immune system as a source of neural precursor cells. Several types of data in mammals, including adoptive transfers of bone marrow or stem cells as well as the presence of fetal microchimerism, suggest that there must be a population of cells that are able to access the brain and generate new neurons in these species.


Author(s):  
Minmin Zhou ◽  
Shaobo Wang ◽  
Jiao Guo ◽  
Yang Liu ◽  
Junyuan Cao ◽  
...  

Mosquito-borne Japanese encephalitis virus (JEV) causes serious illness worldwide and is associated with high morbidity and mortality. To identify potential host therapeutic targets, a high-throughput receptor tyrosine kinase small interfering RNA library screening was performed with recombinant JEV particles. Platelet-derived growth factor receptor beta (PDGFRβ) was identified as a hit after two rounds of screening. Knockdown of PDGFRβ blocked JEV infection, and trans-complementation of PDGFRβ could partly restore its infectivity. The PDGFRβ inhibitor imatinib, which has been approved for the treatment of malignant metastatic cancer, protected mice against JEV-induced lethality by decreasing the viral load in the brain, while abrogating the histopathological changes associated with JEV infection. These findings demonstrated that PDGFRβ is important in viral infection and provided evidence for the potential to develop imatinib as a therapeutic intervention against JEV infection.


2021 ◽  
Vol 2 ◽  
Author(s):  
Matthew Dodson ◽  
Annadurai Anandhan ◽  
Donna D. Zhang ◽  
Lalitha Madhavan

Redox and metabolic mechanisms lie at the heart of stem cell survival and regenerative activity. NRF2 is a major transcriptional controller of cellular redox and metabolic homeostasis, which has also been implicated in ageing and lifespan regulation. However, NRF2’s role in stem cells and their functioning with age is only just emerging. Here, focusing mainly on neural stem cells, which are core to adult brain plasticity and function, we review recent findings that identify NRF2 as a fundamental player in stem cell biology and ageing. We also discuss NRF2-based molecular programs that may govern stem cell state and function with age, and implications of this for age-related pathologies.


2021 ◽  
Vol 4 (1) ◽  
pp. 23-41
Author(s):  
Alexandra-Elena Dobranici ◽  
Sorina Dinescu ◽  
Marieta Costache

Specialised cells of the brain are generated from a population of multipotent stem cells found in the forming embryo and adult brain after birth, called neural stem cells. They reside in specific niches, usually in a quiescent, non-proliferating state that maintains their reservoir. Neural stem cells are kept inactive by various cues such as direct cell-cell contacts with neighbouring cells or by soluble molecules that trigger intracellular responses. They are activated in response to injuries, physical exercise, or hypoxia condition, through stimulation of signaling pathways that are usually correlated with increased proliferation and survival. Moreover, mature neurons play essential role in regulating the balance between active and quiescent state by realising inhibitory or activating neurotransmitters. Understanding molecular mechanisms underlying neuronal differentiation is of great importance in elucidating pathological conditions of the brain and treating neurodegenerative disorders that until now have no efficient therapies.


Impact ◽  
2020 ◽  
Vol 2020 (7) ◽  
pp. 28-30
Author(s):  
Ken Tachibana

The biological development of a human is an extremely complex and delicate process. It starts from fertilisation and continues until long after birth. The creation and development of the brain is particularly complicated and susceptible to disruptions to its progression. The primary cells responsible for the development of the brain are the neural stem cells. These are a broad class of cells that can differentiate into the wide range of cell types that form the adult brain. To achieve this complex process, different cells need to undergo a range of gene expression changes at the right time. This is delicate and its disturbance is a key cause of pathology in a wide range of diseases. There are many external factors that are known to disrupt neural development however, there are several common chemicals whose effects remain largely unknown. One such group are broadly described as nanoparticles. These are small particles that are being increasingly used by many industries as they can help in the creation of products with better properties. However, their effect on the environment and the human body – particularly that of a developing brain – have been largely unexamined. Associate Professor Ken Tachibana of the Division of Hygienic Chemistry, Sanyo-Onoda City University, Japan is researching the effects of nanoparticles on neural development.


Sign in / Sign up

Export Citation Format

Share Document